Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells
| Autor: | May San Martinho, David G. Beer, Zhuwen Wang, Paramita Ray, Jules Lin, Dafydd G. Thomas, Derek J. Nancarrow, Dipankar Ray, Daysha Ferrer-Torres, Kiran H. Lagisetty, Scott R. Owens, Theodore S. Lawrence, Hui Jiang, Tonaye Hinton, Hee-won Yoon, Andrew C. Chang |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Gene isoform Simvastatin Small interfering RNA Glycosylation Esophageal Neoplasms Ubiquitin-Protein Ligases Mutant Down-Regulation Gene Expression Mice Nude Adenocarcinoma Article Barrett Esophagus Interferon-gamma Mice 03 medical and health sciences Esophagus 0302 clinical medicine RNF128 Animals Humans Gene Silencing RNA Messenger Cells Cultured chemistry.chemical_classification DNA ligase Hepatology biology Chemistry Gastroenterology Transfection Molecular biology Ubiquitin ligase Isoenzymes 030104 developmental biology biology.protein Female 030211 gastroenterology & hepatology SCF ubiquitin ligase complex Hydroxymethylglutaryl-CoA Reductase Inhibitors Tumor Suppressor Protein p53 Neoplasm Transplantation Signal Transduction |
| Zdroj: | Gastroenterology |
| ISSN: | 0016-5085 |
| Popis: | Background & Aims Barrett's esophagus (BE) can progress to dysplasia and esophageal adenocarcinoma (EAC), accompanied by mutations in TP53 that increase the stability of its product, p53. We analyzed BE tissues for messenger RNAs (mRNAs) that associate with BE progression and identified one that affects the stabilization of p53. Methods We obtained 54 BE samples collected from patients with high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC), from 1992 through 2015, and performed RNA sequence analyses, including isoform-specific analyses. We performed reverse-transcription polymerase chain reaction analyses of 166 samples and immunohistochemical analyses of tissue microarrays that contained BE tissues from 100 patients with HGD or EAC and normal esophageal squamous mucosa (controls). Proteins were expressed from transfected plasmids or knocked down with small interfering RNAs in BE cells and analyzed by immunoblots and in immunoprecipitation and ubiquitin ligase assays. Athymic nude mice bearing EAC xenograft tumors (grown from OE-33 cells) were given intraperitoneal injections of simvastatin; tumor growth was monitored and tumors were collected and analyzed by immunoblotting for levels of RNF128, p53, and acetylated p53. Results Progression of BE to HGD or EAC associated with changes in expression of mRNAs that encoded mucins and promoted inflammation and activation of ATM and the DNA damage response. As tissues progressed from BE to HGD to EAC, they increased expression of mRNAs encoding isoform 1 of RNF128 (Iso1) and decreased expression of Iso2 of RNF128. RNF128 is an E3 ubiquitin ligase that targets p53 for degradation. Incubation of BE cells with interferon gamma caused them to increase expression of Iso1 and reduce expression of Iso2. Iso1 was heavily glycosylated with limited ubiquitin ligase activity for p53, resulting in p53 stabilization. Knockdown of Iso1 in BE and EAC cells led to degradation of the mutant form of p53 and reduced clonogenic survival. In contrast, Iso2 was a potent ligase that reduced levels of the mutant form of p53 in BE cells. In BE cells, Iso2 was hypoglycosylated and degraded, via ATM and GSK3β-mediated phosphorylation and activation of the beta-TrCP1-containing SCF ubiquitin ligase complex. Simvastatin, which degrades the mutant form of p53, also degraded RNF128 Iso1 protein in BE cells and slowed growth of EAC xenograft tumors in mice. Conclusions We found that isoform 2 of RNF128 is decreased in BE cells, resulting in increased levels of mutant p53, whereas isoform 1 of RNF128 is increased in BE cells, further promoting the stabilization of mutant p53. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|